Analysis of biological small molecule mixtures using multiple modes of mass spectrometric fragmentation coupled with new bioinformatics workflows

使用多种质谱裂解模式结合新的生物信息学工作流程分析生物小分子混合物

基本信息

  • 批准号:
    BB/X019802/1
  • 负责人:
  • 金额:
    $ 103.23万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Liquid chromatography-mass spectrometry (LC-MS) is an essential technique in the chemical, biological and biomedical sciences. To start with, a mixture of small molecules is separated (LC) followed by ionisation. After this, they enter the MS and are accelerated followed by separation according to their mass and detection of the ions. If additional energy is provided, the molecules will fragment into ions which are diagnostic of their structure. Modern systems have very high resolution to determine the molecular formulas with high accuracy. Fragments can be generated at different levels of energy and their formulas can also be determined.We are bidding for a LC-MS system to enable the profiling and identification of small molecule components in complex biological mixtures. Small molecules have important roles in biology such as communication within or between organisms or interacting with receptors with important biological effects. Fundamental questions in biology, ecology, physiology, biochemistry, biosynthesis and human disease can only be answered by studying these complex molecular mixtures and understanding how they work. The proposed system will enable efficient fast separation of complex biological mixtures followed by the accurate determination of the molecular formulas of each of the components. As there are many molecular structures possible for each molecular formula, the ability to fragment molecules with different levels of energy is essential to increase confidence in molecular identification. Applications include discovery and synthesis of small bioactive natural products, the understanding of biological synthesis of small molecules, understanding of microbial processes in soil and the chemical communication between sponges and molluscs, the understanding of disease causation as well as pharmaceutical discovery. Parameters for selecting the equipment are: high mass accuracy at low molecular weights; a range of separation and fragmentation modes and a high dynamic range including the possibility of fragmenting peaks differing in intensity by 3-5 orders of magnitude. The critical factor is the ability to accurately and quickly identify compounds present at very low abundance. We have selected the Thermo Scientific Orbitrap IQ-X Tribrid Mass Spectrometer which has a quadrupole analyser, ultra-high field orbitrap and an ion trap analyser and is promoted specifically for small molecule analysis. Our previous experience of systems from this manufacturer is that they have a very high dynamic range, are very robust with a long lifetime and have excellent service support.To demonstrate the utility of this system we have chosen 6 different projects: discovery of new bioactive compounds from deep-sea and gut bacteria; discovery of new enzymes that can be used in industrial biotechnology and synthetic biology; the discovery, biosynthesis and automated analysis of cyclic peptides which are becoming of major importance in drug discovery; to study variations in metabolism in marine invertebrates and barley; to understand the role of modified peptides in the causation of human disease; analysis of traditional medicine use in archaeological artefacts.The new MS will also enable us to train the next generation of scientists on the most advanced MS, which will allow them to gain hands-on experience that will be extremely beneficial for their future career development. Our research-led teaching means that even undergraduate students can benefit from the access to a state-of-the art facility. The proposed instrument will be incorporated into and will complement and significantly enhance our existing MS facility though the addition of new capabilities. The new LC-MS will not only benefit our students and staff in Aberdeen, but our academic and industrial collaborators will also benefit from receiving training and having access to the most advanced MS technologies.
液相色谱-质谱联用技术(LC-MS)是化学、生物和生物医学科学中必不可少的技术。首先,将小分子的混合物分离(LC),然后电离。之后,它们进入MS并被加速,然后根据它们的质量和离子检测进行分离。如果提供额外的能量,分子将分裂成离子,这是其结构的诊断。现代系统具有非常高的分辨率,可以高精度地确定分子式。可以在不同的能量水平下生成片段,也可以确定它们的分子式。我们正在竞标LC-MS系统,以便能够分析和鉴定复杂生物混合物中的小分子成分。小分子在生物学中具有重要作用,例如生物体内或生物体之间的通信或与具有重要生物效应的受体相互作用。生物学、生态学、生理学、生物化学、生物合成和人类疾病中的基本问题只能通过研究这些复杂的分子混合物并了解它们如何工作来回答。所提出的系统将能够有效地快速分离复杂的生物混合物,然后准确地确定每个组分的分子式。由于每个分子式可能有许多分子结构,因此以不同能量水平将分子片段化的能力对于提高分子鉴定的置信度至关重要。应用包括发现和合成小的生物活性天然产物,了解小分子的生物合成,了解土壤中的微生物过程以及海绵和软体动物之间的化学通讯,了解疾病的原因以及药物发现。选择设备的参数是:低分子量下的高质量准确度;一系列分离和裂解模式以及高动态范围,包括裂解强度相差3-5个数量级的峰的可能性。关键因素是能够准确和快速地识别丰度非常低的化合物。我们选择了Thermo Scientific轨道阱IQ-X Tribrid质谱仪,该质谱仪具有四极分析仪,超高场轨道阱和离子阱分析仪,专门用于小分子分析。我们以前使用过的这个制造商的系统的经验是,它们具有非常高的动态范围,非常坚固耐用,使用寿命长,并且具有出色的服务支持。为了证明这个系统的实用性,我们选择了6个不同的项目:从深海和肠道细菌中发现新的生物活性化合物;发现可用于工业生物技术和合成生物学的新酶;环肽的发现,生物合成和自动化分析在药物发现中变得非常重要;研究海洋无脊椎动物和大麦的代谢变化;了解修饰肽在人类疾病病因中的作用;分析传统医学在考古文物中的应用。新的MS还将使我们能够在最先进的MS上培训下一代科学家,这将使他们获得实践经验,这将对他们未来的职业发展非常有益。我们以研究为主导的教学意味着即使是本科生也可以从获得最先进的设施中受益。拟议的仪器将被纳入,并将补充和显着提高我们现有的MS设施,通过增加新的能力。新的LC-MS不仅有利于我们在阿伯丁的学生和工作人员,而且我们的学术和工业合作者也将受益于接受培训和获得最先进的MS技术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marcel Jaspars其他文献

New nodulopeptins from <em>Nodularia spumigena</em> KAC 66
  • DOI:
    10.1016/j.tet.2011.11.056
  • 发表时间:
    2012-02-04
  • 期刊:
  • 影响因子:
  • 作者:
    Marc Schumacher;Neil Wilson;Jioji N. Tabudravu;Christine Edwards;Linda A. Lawton;Cherie Motti;Anthony D. Wright;Marc Diederich;Marcel Jaspars
  • 通讯作者:
    Marcel Jaspars
Pseudochelin A, a siderophore of <em>Pseudoalteromonas piscicida</em> S2040
  • DOI:
    10.1016/j.tet.2017.03.051
  • 发表时间:
    2017-05-04
  • 期刊:
  • 影响因子:
  • 作者:
    Eva C. Sonnenschein;Marc Stierhof;Stephan Goralczyk;Floriane M. Vabre;Leonie Pellissier;Kine Østnes Hanssen;Mercedes de la Cruz;Caridad Díaz;Peter de Witte;Daniëlle Copmans;Jeanette Hammer Andersen;Espen Hansen;Venke Kristoffersen;José R. Tormo;Rainer Ebel;Bruce F. Milne;Hai Deng;Lone Gram;Marcel Jaspars;Jioji N. Tabudravu
  • 通讯作者:
    Jioji N. Tabudravu
<em>Commiphora gileadensis</em> sap extract induces cell cycle-dependent death in immortalized keratinocytes and human dermoid carcinoma cells
  • DOI:
    10.1016/j.hermed.2015.08.001
  • 发表时间:
    2015-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Eitan Wineman;Iain Douglas;Vanessa Wineman;Ksenia Sharova;Marcel Jaspars;Shiri Meshner;Zvi Bentwich;Guy Cohen;Avi Shtevi
  • 通讯作者:
    Avi Shtevi
A talented genus
一个有才华的属
  • DOI:
    10.1038/nature13049
  • 发表时间:
    2014-01-29
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Marcel Jaspars;Greg Challis
  • 通讯作者:
    Greg Challis
Natural product diversity of actinobacteria in the Atacama Desert

Marcel Jaspars的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marcel Jaspars', 18)}}的其他基金

HOTBIO - A Holistic Approach to Training a new Generation of Scientists in Marine Biodiscovery
HOTBIO - 培训新一代海洋生物发现科学家的整体方法
  • 批准号:
    EP/X029999/1
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
K KYEREMEH, Ghana - Development of Novel Therapeutics for Parasite Infections and Cancer by Multi-step Microbial Biodiscovery Processes and iChip
K KYEREMEH,加纳 - 通过多步微生物生物发现过程和 iChip 开发寄生虫感染和癌症的新型疗法
  • 批准号:
    MR/S00520X/1
  • 财政年份:
    2018
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
Industrial scale production of cyanobactin enzymes for fast and efficient cyclic peptide synthesis
工业规模生产蓝菌素酶,用于快速高效的环肽合成
  • 批准号:
    BB/M013669/1
  • 财政年份:
    2015
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
Enhanced productivity and functionality of Modified Ribosomally Produced Peptides (M-RIPPs)
增强修饰核糖体产生的肽 (M-RIPP) 的生产力和功能
  • 批准号:
    BB/M028526/1
  • 财政年份:
    2015
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
13TSB_SynBio Enhanced discovery and scalable synthesis of therapeutic cyclic peptides
13TSB_SynBio 治疗性环肽的增强发现和规模化合成
  • 批准号:
    BB/L004429/1
  • 财政年份:
    2013
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
Biosynthesis of five-membered heterocyclic rings
五元杂环的生物合成
  • 批准号:
    BB/K015176/1
  • 财政年份:
    2013
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Research Grant
Biosynthesis and exploitation of marine-derived post-translationally modified ribosomal peptides
海洋来源的翻译后修饰核糖体肽的生物合成和开发
  • 批准号:
    BB/D020360/1
  • 财政年份:
    2006
  • 资助金额:
    $ 103.23万
  • 项目类别:
    Fellowship

相似国自然基金

生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
过表达CX45联合HCN4基因转染对起搏细胞自律性的影响
  • 批准号:
    81170174
  • 批准年份:
    2011
  • 资助金额:
    50.0 万元
  • 项目类别:
    面上项目
美洲大蠊药材养殖及加工过程中化学成分动态变化与生物活性的相关性研究
  • 批准号:
    81060329
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
慢病毒转染嵌合体HCN1+4拼接基因构建生物起搏细胞
  • 批准号:
    81070139
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目
岭南瑶区几种瑶族抗肝炎植物药的化学成分及生物活性研究
  • 批准号:
    20772047
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
TB方法在有机和生物大分子体系计算研究中的应用
  • 批准号:
    20773047
  • 批准年份:
    2007
  • 资助金额:
    26.0 万元
  • 项目类别:
    面上项目
天然生物材料的多尺度力学与仿生研究
  • 批准号:
    10732050
  • 批准年份:
    2007
  • 资助金额:
    200.0 万元
  • 项目类别:
    重点项目

相似海外基金

Customizable Artificial Intelligence for the Biomedical Masses: Development of a User-Friendly Automated Machine Learning Platform for Biology Image Analysis.
面向生物医学大众的可定制人工智能:开发用于生物图像分析的用户友好的自动化机器学习平台。
  • 批准号:
    10699828
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
Jansen de Vries 综合征中发现的含有 PPM1D 截短突变的 iPSC 衍生的谷氨酸能神经元的分子分析
  • 批准号:
    10573782
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
  • 批准号:
    10761217
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Discovering clinical endpoints of toxicity via graph machine learning and semantic data analysis
通过图机器学习和语义数据分析发现毒性的临床终点
  • 批准号:
    10745593
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort
使用 DNA 修复功能测定和 PLCO 前瞻性队列冷冻保存的血液样本分析肺癌的可预测性
  • 批准号:
    10641094
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Meta-Analysis of Metabolic Determinants of Exercise Response in Common Funds Data
共同基金数据中运动反应代谢决定因素的荟萃分析
  • 批准号:
    10772237
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Project 1 Mouse Models Analysis
项目1 小鼠模型分析
  • 批准号:
    10729466
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Genetic analysis of beneficial bacterial colonization
有益细菌定植的遗传分析
  • 批准号:
    10555034
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Development of a sample preparation protocol for 3D kidney ultrastructural analysis and immunolabeling by light microscopy
开发用于 3D 肾脏超微结构分析和光学显微镜免疫标记的样品制备方案
  • 批准号:
    10760947
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
Analysis of Whole Genome Sequence and Hemostasis Phenotypes
全基因组序列和止血表型分析
  • 批准号:
    10654394
  • 财政年份:
    2023
  • 资助金额:
    $ 103.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了